These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 37016755)
41. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine. Svetlov SI; Kobeissy FH; Gold MS J Addict Dis; 2007; 26(4):1-6. PubMed ID: 18032226 [TBL] [Abstract][Full Text] [Related]
42. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials. Castells X; Kosten TR; Capellà D; Vidal X; Colom J; Casas M Am J Drug Alcohol Abuse; 2009; 35(5):339-49. PubMed ID: 20180662 [TBL] [Abstract][Full Text] [Related]
43. Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials. Castells X; Casas M; Vidal X; Bosch R; Roncero C; Ramos-Quiroga JA; Capellà D Addiction; 2007 Dec; 102(12):1871-87. PubMed ID: 18031423 [TBL] [Abstract][Full Text] [Related]
44. The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update. Mariani JJ; Khantzian EJ; Levin FR Am J Addict; 2014; 23(2):189-93. PubMed ID: 25187055 [TBL] [Abstract][Full Text] [Related]
45. Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021. Friedman J; Shover CL Addiction; 2023 Dec; 118(12):2477-2485. PubMed ID: 37705148 [TBL] [Abstract][Full Text] [Related]
46. State-Level History of Overdose Deaths Involving Stimulants in the United States, 1999‒2020. Kline D; Bunting AM; Hepler SA; Rivera-Aguirre A; Krawczyk N; Cerda M Am J Public Health; 2023 Sep; 113(9):991-999. PubMed ID: 37556789 [No Abstract] [Full Text] [Related]
47. Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder. Yoon JH; Suchting R; McKay SA; San Miguel GG; Vujanovic AA; Stotts AL; Lane SD; Vincent JN; Weaver MF; Lin A; Schmitz JM Psychol Addict Behav; 2020 Feb; 34(1):164-174. PubMed ID: 31233323 [TBL] [Abstract][Full Text] [Related]
48. Galantamine and Computerized Cognitive Behavioral Therapy for Cocaine Dependence: A Randomized Clinical Trial. Carroll KM; Nich C; DeVito EE; Shi JM; Sofuoglu M J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29286595 [TBL] [Abstract][Full Text] [Related]
49. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders. Harada T; Tsutomi H; Mori R; Wilson DB Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011315. PubMed ID: 30577083 [TBL] [Abstract][Full Text] [Related]
51. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Rawson RA; Huber A; McCann M; Shoptaw S; Farabee D; Reiber C; Ling W Arch Gen Psychiatry; 2002 Sep; 59(9):817-24. PubMed ID: 12215081 [TBL] [Abstract][Full Text] [Related]
52. How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis. Levin FR; Choi CJ; Pavlicova M; Mariani JJ; Mahony A; Brooks DJ; Nunes EV; Grabowski J Drug Alcohol Depend; 2018 Jul; 188():135-140. PubMed ID: 29775957 [TBL] [Abstract][Full Text] [Related]
54. Contingency management for substance use disorders in Spain: Implications for research and practice. Secades-Villa R; García-Rodríguez O; Fernández-Hermida JR Prev Med; 2015 Nov; 80():82-8. PubMed ID: 26164071 [TBL] [Abstract][Full Text] [Related]
55. Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial. Blanken P; Nuijten M; van den Brink W; Hendriks VM Addiction; 2020 May; 115(5):917-923. PubMed ID: 31908066 [TBL] [Abstract][Full Text] [Related]
56. Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects. Maguire DR; Minervini V Adv Pharmacol; 2022; 93():1-33. PubMed ID: 35341563 [TBL] [Abstract][Full Text] [Related]
58. Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature. Leidl D; Takhar P; Li H Int J Ment Health Nurs; 2023 Oct; 32(5):1225-1242. PubMed ID: 36978242 [TBL] [Abstract][Full Text] [Related]
59. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Ciccarone D Curr Opin Psychiatry; 2021 Jul; 34(4):344-350. PubMed ID: 33965972 [TBL] [Abstract][Full Text] [Related]
60. Cocaine abstinence during the "critical period" of a contingency management trial predicts future abstinence in people with cocaine use disorder. Regnier SD; Shellenberg TP; Koffarnus MN; Cox DH; Lile JA; Rush CR; Stoops WW Drug Alcohol Depend; 2023 Dec; 253():111030. PubMed ID: 38006674 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]